AbstractHIV-1 variants evolving in AIDS patients frequently show increased replicative capacity compared to those present during early asymptomatic infection. It is known that late stage HIV-1 variants often show an expanded coreceptor tropism and altered Nef function. In the present study we investigated whether enhanced HIV-1 LTR promoter activity might also evolve during disease progression. Our results demonstrate increased LTR promoter activity after AIDS progression in 3 of 12 HIV-1-infected individuals studied. Further analysis revealed that multiple alterations in the U3 core-enhancer and in the transactivation-response (TAR) region seem to be responsible for the enhanced functional activity. Our findings show that in a subset of HI...
Recent data has indicated that the prolonged asymptomatic phase and freedom from clinical illness ex...
AbstractWe have previously described an in vitro primary thymocyte model for HIV latency that recapi...
Human immunodeficiency virus type 1 (HIV-1) Tat is a mediator of viral transcription and is involved...
AbstractHIV-1 variants evolving in AIDS patients frequently show increased replicative capacity comp...
HIV-1 variants evolving in AIDS patients frequently show increased replicative capacity compared to ...
AbstractDifferent rates of disease progression may be associated with different human immunodeficien...
Masters Degree. University of KwaZulu-Natal, Durban.Background: The persistence of latent viral rese...
AbstractIt has been widely demonstrated that the human immunodeficiency virus type 1 (HIV-1) envelop...
A genetic bottleneck is a hallmark of HIV-1 transmission such that only very few viral strains, term...
AbstractAbout 38% of primary HIV-1 long terminal repeats (LTRs) contain an insertion (consensus: 5′-...
AbstractWe determined the effect of mutations generated in HIV-1 LTR on viral gene expression in six...
Following integration, HIV-1 in most cases produces active infection events; however, in some rare i...
AbstractIt has been widely demonstrated that the human immunodeficiency virus type 1 (HIV-1) envelop...
The large majority of human immunodeficiency virus type 1 (HIV-1) markers of disease progression/sev...
AbstractDifferent rates of disease progression may be associated with different human immunodeficien...
Recent data has indicated that the prolonged asymptomatic phase and freedom from clinical illness ex...
AbstractWe have previously described an in vitro primary thymocyte model for HIV latency that recapi...
Human immunodeficiency virus type 1 (HIV-1) Tat is a mediator of viral transcription and is involved...
AbstractHIV-1 variants evolving in AIDS patients frequently show increased replicative capacity comp...
HIV-1 variants evolving in AIDS patients frequently show increased replicative capacity compared to ...
AbstractDifferent rates of disease progression may be associated with different human immunodeficien...
Masters Degree. University of KwaZulu-Natal, Durban.Background: The persistence of latent viral rese...
AbstractIt has been widely demonstrated that the human immunodeficiency virus type 1 (HIV-1) envelop...
A genetic bottleneck is a hallmark of HIV-1 transmission such that only very few viral strains, term...
AbstractAbout 38% of primary HIV-1 long terminal repeats (LTRs) contain an insertion (consensus: 5′-...
AbstractWe determined the effect of mutations generated in HIV-1 LTR on viral gene expression in six...
Following integration, HIV-1 in most cases produces active infection events; however, in some rare i...
AbstractIt has been widely demonstrated that the human immunodeficiency virus type 1 (HIV-1) envelop...
The large majority of human immunodeficiency virus type 1 (HIV-1) markers of disease progression/sev...
AbstractDifferent rates of disease progression may be associated with different human immunodeficien...
Recent data has indicated that the prolonged asymptomatic phase and freedom from clinical illness ex...
AbstractWe have previously described an in vitro primary thymocyte model for HIV latency that recapi...
Human immunodeficiency virus type 1 (HIV-1) Tat is a mediator of viral transcription and is involved...